Skinvive by Juvéderm

A Different Conversation to Traditional Fillers 

While dermal fillers remain a core part of many aesthetic practices, patient expectations are evolving. 

Not every consultation is about contouring, lifting, or volume restoration. Increasingly, clinics are seeing patients who want fresher-looking skin, improved texture, and subtle aesthetic maintenance—without the visible change associated with conventional filler treatment. 

Part of the Juvéderm portfolio from Allergan Aesthetics, Skinvive sits within the injectable skin quality category, designed to improve skin smoothness and hydration through intradermal hyaluronic acid treatment rather than structural augmentation. 

For clinics, this creates a distinct treatment proposition—particularly for patients who may not be seeking traditional filler outcomes but are still interested in injectable aesthetic treatments. 

Why Clinics May Be Paying Attention 

The commercial opportunity goes beyond simply adding another injectable. 

Skin quality treatments can help clinics broaden consultation pathways, particularly with patients interested in preventative aesthetics, maintenance-focused treatment plans, or lower-commitment injectable options. 

They also sit naturally alongside existing clinic offerings. 

For practices already delivering toxin treatments, dermal fillers, energy-based procedures, or regenerative injectables, skin-focused injectable treatments can provide a complementary addition rather than a competing one. 

That creates practical upsell and combination treatment opportunities while supporting more personalised treatment planning. 

There is also the brand factor. 

Patient familiarity with the Juvéderm name may carry weight in consultation settings, particularly as aesthetic consumers become increasingly informed and product-aware. 

The Skin Quality Category Keeps Growing 

The rise of injectable skin boosters and hydration-focused treatments reflects a wider shift in the aesthetics market. 

Patients are becoming more interested in “maintenance” aesthetics—treatments that support healthier-looking skin and subtle improvement rather than obvious transformation. 

That shift has created stronger demand for products positioned between traditional skincare and volumising injectables. 

For clinics, offering category diversity matters. 

A broader injectable portfolio can help practitioners better match treatment recommendations to patient goals, while also creating more touchpoints for repeat engagement and longer-term treatment planning. 

Skinvive’s positioning within a recognised global injectable brand makes it particularly relevant for clinics looking to strengthen premium skin quality offerings. 

Availability 

Skinvive by Juvéderm is now available via Church Pharmacy for UK healthcare professionals. 

Further Information 

Healthcare professionals can find further information or place orders via the Church Pharmacy website or by contacting the team directly.